home about categories posts news
discussions archive recommendations faq contacts

High Annual Fee Card Offers Valuable Travel Perks

January 21, 2025 - 18:28

High Annual Fee Card Offers Valuable Travel Perks

Although the American Express Platinum card has a high annual fee, the free Priority Pass membership and other travel perks make it worth it for me. With an annual cost of $695, many might hesitate to sign up for this credit card. However, the numerous benefits it provides can easily outweigh the initial expense for frequent travelers.

One of the standout features is the complimentary Priority Pass membership, which grants access to over 1,300 airport lounges worldwide. This can significantly enhance the travel experience, providing a comfortable space to relax before flights, along with complimentary refreshments. Additionally, the card offers various travel insurance options, including trip cancellation and lost luggage coverage, which can provide peace of mind.

Moreover, cardholders can earn generous rewards points on purchases, which can be redeemed for flights, hotel stays, or other travel-related expenses. Overall, while the annual fee may seem steep, the savings and benefits associated with the card can make it a smart investment for those who travel frequently.


MORE NEWS

Macquarie Group Surpasses Profit Expectations Despite Challenges in Market Sectors

May 9, 2025 - 10:04

Macquarie Group Surpasses Profit Expectations Despite Challenges in Market Sectors

Macquarie Group Ltd. has reported an annual profit that exceeded analysts` expectations, showcasing resilience in a fluctuating market environment. The financial services provider benefited...

Exploring the Intersection of Business and Improv Theater through AI

May 9, 2025 - 02:32

Exploring the Intersection of Business and Improv Theater through AI

In an intriguing blend of creativity and technology, a theater director is leading an AI-powered improv troupe, drawing fascinating parallels between the worlds of business and improvisational...

Edgewise Therapeutics Shares Positive Phase 2 Results and Financial Updates

May 8, 2025 - 19:53

Edgewise Therapeutics Shares Positive Phase 2 Results and Financial Updates

Edgewise Therapeutics has announced encouraging top-line results from its Phase 2 CIRRUS-HCM trial of EDG-7500, a treatment aimed at addressing Hypertrophic Cardiomyopathy (HCM). This trial is a...

Tariffs Create Challenges for Erlanger's Post Glover Resistors

May 8, 2025 - 01:07

Tariffs Create Challenges for Erlanger's Post Glover Resistors

Post Glover Resistors, a company based in Erlanger, is facing significant challenges due to tariffs that affect its international supply chain. As a business that relies on suppliers and customers...

read all news
home categories posts about news

Copyright © 2025 Bizrux.com

Founded by: Baylor McFarlin

discussions archive recommendations faq contacts
terms of use privacy policy cookie policy